Community Bank N.A. decreased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 49,666 shares of the company’s stock after selling 1,458 shares during the period. Procter & Gamble makes up approximately 1.0% of Community Bank N.A.’s holdings, making the stock its 24th largest position. Community Bank N.A.’s holdings in Procter & Gamble were worth $7,913,000 as of its most recent filing with the SEC.
Several other hedge funds have also made changes to their positions in PG. Kingstone Capital Partners Texas LLC boosted its stake in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC acquired a new stake in Procter & Gamble in the first quarter valued at about $1,954,941,000. Price T Rowe Associates Inc. MD lifted its position in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. lifted its position in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC lifted its position in Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Down 1.4%
Shares of Procter & Gamble stock opened at $147.54 on Tuesday. Procter & Gamble Company has a 12-month low of $146.96 and a 12-month high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The stock has a market cap of $345.32 billion, a PE ratio of 22.66, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36. The company has a 50-day moving average of $155.18 and a two-hundred day moving average of $159.27.
Insider Buying and Selling at Procter & Gamble
In other news, COO Shailesh Jejurikar sold 13,039 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the transaction, the chief operating officer directly owned 28,036 shares of the company’s stock, valued at $4,409,221.72. This trade represents a 31.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Marc S. Pritchard sold 9,849 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider directly owned 182,422 shares of the company’s stock, valued at approximately $28,689,507.94. This trade represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by insiders.
Analysts Set New Price Targets
PG has been the subject of a number of recent analyst reports. Barclays reduced their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. BNP Paribas restated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Evercore ISI restated an “in-line” rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Finally, Wells Fargo & Company dropped their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a report on Thursday, September 25th. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $172.21.
Get Our Latest Stock Analysis on Procter & Gamble
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- How Can Investors Benefit From After-Hours Trading
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- Using the MarketBeat Dividend Tax Calculator
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- 3 Fintech Stocks With Good 2021 Prospects
- Datavault: A Speculative AI Play, But Beware of Volatility
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.